An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells

[1]  Chad Tang,et al.  Potential barriers to therapeutics utilizing pluripotent cell derivatives: intrinsic immunogenicity of in vitro maintained and matured populations , 2011, Seminars in Immunopathology.

[2]  K. Khoo,et al.  Switching of the core structures of glycosphingolipids from globo- and lacto- to ganglio-series upon human embryonic stem cell differentiation , 2010, Proceedings of the National Academy of Sciences.

[3]  Irving L. Weissman,et al.  Human Melanoma Initiating Cells Express Neural Crest Nerve Growth Factor Receptor CD271 , 2010, Nature.

[4]  Debashis Sahoo,et al.  MiDReG: A method of mining developmentally regulated genes using Boolean implications , 2010, Proceedings of the National Academy of Sciences.

[5]  D. Sahoo,et al.  Ly6d marks the earliest stage of B-cell specification and identifies the branchpoint between B-cell and T-cell development. , 2009, Genes & development.

[6]  K. Sermon,et al.  Characterization of CD30 expression in human embryonic stem cell lines cultured in serum-free media and passaged mechanically. , 2009, Human reproduction.

[7]  A. Connolly,et al.  Effects of cell number on teratoma formation by human embryonic stem cells , 2009, Cell cycle.

[8]  M. Yap,et al.  mAb 84, a Cytotoxic Antibody that Kills Undifferentiated Human Embryonic Stem Cells via Oncosis , 2009, Stem cells.

[9]  T. Putti,et al.  Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies. , 2009, Stem cell research.

[10]  P. Stanley,et al.  Complex N-glycans or core 1-derived O-glycans are not required for the expression of stage-specific antigens SSEA-1, SSEA-3, SSEA-4, or LeY in the preimplantation mouse embryo , 2009, Glycoconjugate Journal.

[11]  Robert Tibshirani,et al.  Boolean implication networks derived from large scale, whole genome microarray datasets , 2008, Genome Biology.

[12]  Toshiaki Isobe,et al.  Cell surface biomarkers of embryonic stem cells , 2008, Proteomics.

[13]  Miranda Yap,et al.  Selection Against Undifferentiated Human Embryonic Stem Cells by a Cytotoxic Antibody Recognizing Podocalyxin‐Like Protein‐1 , 2008, Stem cells.

[14]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[15]  Ahmad Y. Sheikh,et al.  Molecular imaging of embryonic stem cell misbehavior and suicide gene ablation. , 2007, Cloning and stem cells.

[16]  M. Vodyanik,et al.  Hematoendothelial Differentiation of Human Embryonic Stem Cells , 2007, Current protocols in cell biology.

[17]  Martin Pera,et al.  A method for genetic modification of human embryonic stem cells using electroporation , 2007, Nature Protocols.

[18]  Wei Lang,et al.  Advancing glycomics: implementation strategies at the consortium for functional glycomics. , 2006, Glycobiology.

[19]  Takumi Miura,et al.  Long‐term culture of human embryonic stem cells in feeder‐free conditions , 2004, Developmental dynamics : an official publication of the American Association of Anatomists.

[20]  M. Schuldiner,et al.  Selective Ablation of Human Embryonic Stem Cells Expressing a “Suicide” Gene , 2003, Stem cells.

[21]  J. Thomson,et al.  Surface antigens of human embryonic stem cells: changes upon differentiation in culture * , 2002, Journal of anatomy.

[22]  S S Gambhir,et al.  Noninvasive optical imaging of firefly luciferase reporter gene expression in skeletal muscles of living mice. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[23]  C. Racowsky,et al.  Blastocyst-ET and Monozygotic Twinning , 2000, Journal of Assisted Reproduction and Genetics.

[24]  A. Trounson,et al.  Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro , 2000, Nature Biotechnology.

[25]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[26]  J. D. Di Santo,et al.  Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor gamma chain. , 1998, British journal of haematology.

[27]  E. Blasco,et al.  Immunohistological patterns of blood group ABO and type 1 chain (Lewis a Lewis b) and type 2 chain (H-2, Y) antigens in normal uterine cervix. , 1990, Tissue antigens.

[28]  D. Solter,et al.  Stage‐specific embryonic antigens (SSEA‐3 and ‐4) are epitopes of a unique globo‐series ganglioside isolated from human teratocarcinoma cells. , 1983, The EMBO journal.

[29]  D. Solter,et al.  Monoclonal antibody to murine embryos defines a stage-specific embryonic antigen expressed on mouse embryos and human teratocarcinoma cells , 1982, Cell.

[30]  D. Solter,et al.  Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[31]  G. B. Pierce,et al.  MULTIPOTENTIALITY OF SINGLE EMBRYONAL CARCINOMA CELLS. , 1964, Cancer research.

[32]  L. C. Stevens,et al.  Spontaneous Testicular Teratomas in an Inbred Strain of Mice. , 1954, Proceedings of the National Academy of Sciences of the United States of America.

[33]  N. Benvenisty,et al.  The tumorigenicity of human embryonic stem cells. , 2008, Advances in cancer research.

[34]  I. Weissman,et al.  Generation of a monoclonal antibody library against human embryonic stem cells. , 2007, Methods in molecular biology.

[35]  P. Avner,et al.  Three monoclonal antibodies defining distinct differentiation antigens associated with different high molecular weight polypeptides on the surface of human embryonal carcinoma cells. , 1984, Hybridoma.

[36]  S. Hakomori.  Glycosphingolipids in cellular interaction, differentiation, and oncogenesis. , 1981, Annual review of biochemistry.